Newsroom / SARS-CoV-2

In the US, use of the Mitra device is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device can be used as a sample collection device for clinical diagnostic applications, as referenced in some content.

by Neoteryx, on September 23,2021

September 2021 — According to a preprint article slated for publication in the next issue of the journal Bioanalysis, the COVID-19 pandemic led to a shift in the way blood …

Read Story

by Neoteryx, on June 24,2021

June 2021 — According to a research article published online in the June 22, 2021 issue of Science Translational Medicine, data from a sero-surveillance study analyzing blood samples gathered from participants …

Read Story

by Neoteryx, on April 22,2021

At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …

Read Story

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news